Skip to main content


Health

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.
548 of 1531




Newsletter Sign Up

Daily Readings

Reading 1, Jeremiah 18:1-6
The word that came to Jeremiah from Yahweh as follows, 'Get up ... Read More

Psalm, Psalms 146:1-2, 2-4, 5-6
Alleluia! Praise Yahweh, my soul! I will praise Yahweh all my ... Read More

Gospel, Matthew 13:47-53
'Again, the kingdom of Heaven is like a dragnet that is cast in ... Read More

Saint of the Day

July 31 Saint of the Day

St. Ignatius Loyola
July 31: St. Ignatius was born in the family castle in Guip˙zcoa, Spain, ... Read More